High Fusion Inc. (SPLIF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
High Fusion Inc. (SPLIF) trades at $0.00 with AI Score 56/100 (Grade B). High Fusion Inc. operates in the cannabis industry, focusing on the development and manufacturing of branded cannabis products. Market cap: $767,564, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for SPLIF: SPLIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SPLIF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SPLIF: 3/6 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →High Fusion Inc. (SPLIF) Healthcare & Pipeline Overview
High Fusion Inc. is a cannabis company focused on branded products like flower, pro-rolls, vapes, edibles, and oil extracts for the U.S. medical and recreational markets. With brands like FLÏ, OutCo, and Thrive, the company navigates a competitive and regulated industry landscape.
What Is the Investment Thesis for SPLIF?
High Fusion Inc. presents a speculative investment opportunity within the cannabis sector, contingent on successful brand development and market penetration in the U.S. The company's focus on branded products like FLÏ, OutCo, and Thrive aims to capture consumer demand in both medical and recreational markets. However, with a negative profit margin of -330.3% and a market capitalization of 768K, the company faces significant financial challenges. Growth catalysts include expanding its product lines and distribution network. Key risks include navigating regulatory hurdles and competing with established players. Investors should carefully consider the company's financial position and the volatile nature of the cannabis industry.
Based on FMP financials and quantitative analysis
SPLIF Key Highlights
- Focus on branded cannabis products including flower, pro-rolls, vapes, edibles, and oil extracts.
- Operates in the U.S. medical and adult recreational cannabis markets.
- Brand portfolio includes FLÏ edibles and vape products, OutCo, and Thrive.
- Gross margin of 20.0% indicates potential for profitability improvement.
- Negative profit margin of -330.3% signals significant financial challenges.
Who Are SPLIF's Competitors?
SPLIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SPLIF's Key Strengths?
- Established brand portfolio including FLÏ, OutCo, and Thrive.
- Focus on product innovation and development.
- Presence in the growing U.S. cannabis market.
- Expertise in navigating the regulatory environment.
What Are SPLIF's Weaknesses?
- Negative profit margin of -330.3%.
- Limited market capitalization of 768K.
- Dependence on regulatory approvals.
- Intense competition in the cannabis industry.
What Could Drive SPLIF Stock Higher?
- Potential regulatory changes in key U.S. states could expand market access.
- Launch of new product lines targeting specific consumer segments.
- Expansion of distribution network to reach more dispensaries and retailers.
- Increasing consumer awareness and acceptance of cannabis products.
- Strategic partnerships and acquisitions to expand market reach.
What Are the Key Risks for SPLIF?
- Financial-distress signal — its Altman Z-Score of -14.94 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Evolving regulations and changes in cannabis laws could negatively impact operations.
- Intense competition from established players could erode market share.
- Fluctuations in cannabis prices and demand could impact profitability.
- Negative profit margin of -330.3% poses a significant financial challenge.
- Limited market capitalization of 768K restricts access to capital.
What Are the Growth Opportunities for SPLIF?
- Expansion of Product Lines: High Fusion Inc. can expand its product lines to include new and innovative cannabis products, catering to evolving consumer preferences. This includes exploring new flavors, formulations, and delivery methods. The market for cannabis-infused beverages and wellness products is growing rapidly, presenting opportunities for diversification. Timeline: Within the next 1-2 years, High Fusion can introduce new product lines to capture a larger market share.
- Geographic Expansion within the U.S.: High Fusion Inc. can expand its operations to new states within the U.S. as regulations evolve and new markets open up. This includes targeting states with favorable cannabis laws and a growing consumer base. The U.S. cannabis market is projected to reach $43 billion by 2025, offering significant growth potential. Timeline: Over the next 3-5 years, High Fusion can strategically expand its geographic footprint.
- Strategic Partnerships and Acquisitions: High Fusion Inc. can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. This includes partnering with established cannabis companies, retailers, and distributors. Acquisitions can provide access to new technologies, brands, and distribution networks. Timeline: Ongoing, as High Fusion identifies suitable partners and acquisition targets.
- Development of Medical Cannabis Products: High Fusion Inc. can focus on developing medical cannabis products targeting specific health conditions. This includes conducting research and clinical trials to validate the efficacy of its products. The medical cannabis market is growing as more patients and healthcare providers recognize the potential benefits of cannabis for treating various ailments. Timeline: Within the next 2-3 years, High Fusion can develop and launch new medical cannabis products.
- Enhancement of Brand Recognition: High Fusion Inc. can invest in marketing and branding initiatives to enhance brand recognition and build customer loyalty. This includes developing targeted advertising campaigns, sponsoring events, and engaging with consumers on social media. Strong brand recognition can differentiate High Fusion from competitors and drive sales growth. Timeline: Ongoing, as High Fusion continuously invests in its brand.
What Opportunities Does SPLIF Have?
- Expansion of product lines to include new and innovative cannabis products.
- Geographic expansion within the U.S. as regulations evolve.
- Strategic partnerships and acquisitions to expand market reach.
- Development of medical cannabis products targeting specific health conditions.
What Threats Does SPLIF Face?
- Evolving regulations and potential changes in cannabis laws.
- Intense competition from established players.
- Fluctuations in cannabis prices and demand.
- Potential for negative publicity and reputational damage.
What Are SPLIF's Competitive Advantages?
- Brand portfolio including FLÏ, OutCo, and Thrive.
- Focus on product innovation and development.
- Established presence in the U.S. cannabis market.
- Expertise in navigating the complex regulatory environment.
What Does SPLIF Do?
High Fusion Inc., formerly Nutritional High International Inc., was founded in 2004 and rebranded in November 2021 to reflect its evolved focus on the cannabis industry. Headquartered in Toronto, Canada, the company develops and manufactures a range of branded cannabis products, including flower, pre-rolls, vapes, edibles, and oil extracts. These products are specifically designed for both medical and adult recreational use within the United States. High Fusion's brand portfolio includes FLÏ, known for its edibles and vape products, OutCo, and Thrive. The company aims to establish a strong presence in the U.S. cannabis market by offering diverse product lines catering to different consumer preferences. High Fusion navigates the complex regulatory environment of the cannabis industry, focusing on compliance and quality control in its manufacturing processes. The company's strategic focus on branded products aims to differentiate it from competitors and build customer loyalty in a rapidly growing market.
What Products and Services Does SPLIF Offer?
- Develops and manufactures branded cannabis products.
- Focuses on flower, pro-rolls, vapes, edibles, and oil extracts.
- Targets medical and adult recreational users in the United States.
- Manages a portfolio of cannabis brands including FLÏ, OutCo, and Thrive.
- Navigates the complex regulatory environment of the cannabis industry.
- Focuses on compliance and quality control in manufacturing processes.
How Does SPLIF Make Money?
- Develops and manufactures cannabis products.
- Sells products through various distribution channels, including dispensaries and retailers.
- Generates revenue from the sale of branded cannabis products.
- Focuses on building brand recognition and customer loyalty.
What Industry Does SPLIF Operate In?
The cannabis industry is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. High Fusion Inc. operates within the Drug Manufacturers - Specialty & Generic sector, competing with companies like GNOW, HCYTD, LTTSF, NBGV, and PCNT. The market is characterized by intense competition, evolving regulations, and varying consumer preferences. Companies must navigate complex licensing requirements and establish strong brands to succeed. The industry is also subject to political and social factors that can impact growth and profitability.
Who Are SPLIF's Key Customers?
- Medical cannabis patients seeking relief from various health conditions.
- Adult recreational users seeking cannabis products for personal use.
- Dispensaries and retailers that sell cannabis products to consumers.
- Distributors that transport and deliver cannabis products to retailers.
Company Profile
High Fusion Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO William Gillespie. SPLIF has traded publicly since 2015.
High Fusion Inc. (SPLIF) Valuation Context
Valued at 768K, SPLIF is classified as a micro-cap stock. Relative to its peer group, SPLIF's quantitative score of 56/100 is below the peer average of 66/100.
ROE 324%Key Financial Metrics
Return on equity for High Fusion Inc. stands at 324.0%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.28 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
High Fusion Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -14.94 places it in the distress zone, a signal of elevated financial risk.
SPLIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established brand portfolio including FLÏ, OutCo, and Thrive.
- Focus on product innovation and development.
- Presence in the growing U.S. cannabis market.
- Expertise in navigating the regulatory environment.
Bear Case
- Negative profit margin of -330.3%.
- Limited market capitalization of 768K.
- Dependence on regulatory approvals.
- Intense competition in the cannabis industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SPLIF Latest News
No recent news available for SPLIF.
SPLIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SPLIF.
Price Targets
Wall Street price target analysis for SPLIF.
SPLIF MoonshotScore
What does this score mean?
The MoonshotScore rates SPLIF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: William Gillespie
CEO
Information on William Gillespie's background is not available in the provided context. Further research is needed to provide a comprehensive biography, including his career history, education, and previous roles. Without this information, a detailed profile cannot be accurately constructed.
Track Record: Information on William Gillespie's track record is not available in the provided context. Further research is needed to assess his key achievements, strategic decisions, and company milestones under his leadership. Without this information, a detailed assessment cannot be accurately constructed.
SPLIF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that High Fusion Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and regulatory oversight compared to those listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility due to the lack of stringent listing requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial reporting and regulatory oversight.
- Potential for low trading volume and price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited access to capital and financing options.
- Dependence on regulatory approvals and changes in cannabis laws.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and track record.
- Review the company's business plan and growth strategy.
- Evaluate the company's competitive position and market share.
- Analyze the company's regulatory compliance and risk management practices.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Focus on branded cannabis products.
- Presence in the U.S. cannabis market.
- Management team with experience in the cannabis industry.
- Compliance with regulatory requirements.
- Positive media coverage and industry recognition.
SPLIF Healthcare Stock FAQ
What does High Fusion Inc. do?
High Fusion Inc. is involved in the cannabis industry, focusing on the development, manufacturing, and distribution of branded cannabis products. These products include flower, pre-rolls, vapes, edibles, and oil extracts, targeting both the medical and adult recreational markets in the United States. The company's brand portfolio includes FLÏ, OutCo, and Thrive. High Fusion aims to establish a strong presence in the U.S. cannabis market by offering diverse product lines and navigating the complex regulatory environment.
What are the main risks for SPLIF?
The main risks for High Fusion Inc. include evolving regulations and potential changes in cannabis laws, intense competition from established players, fluctuations in cannabis prices and demand, and the company's negative profit margin. As an OTC-listed company, SPLIF faces additional risks related to limited financial reporting, low trading volume, and potential price volatility. Investors should carefully consider these risks before investing in SPLIF.
What are the key factors to evaluate for SPLIF?
High Fusion Inc. (SPLIF) holds an AI score of 56/100 (moderate). Not financial advice.
How frequently does SPLIF data refresh on this page?
SPLIF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SPLIF's recent stock price performance?
High Fusion Inc. (SPLIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand portfolio including FLÏ, OutCo, and Thrive. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SPLIF overvalued or undervalued right now?
Valuing High Fusion Inc. (SPLIF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SPLIF?
Before investing in High Fusion Inc. (SPLIF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SPLIF to a portfolio?
Key strength of High Fusion Inc. (SPLIF): Established brand portfolio including FLÏ, OutCo, and Thrive. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC stocks carry additional risks.